Healthequity (HQY) Return on Capital Employed (2014 - 2026)

Healthequity's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 10.67% for Q2 2026.

• On a quarterly basis, Return on Capital Employed rose 453.0% year-over-year to 10.67% in Q2 2026; TTM through Apr 2026 was 10.67%, a 453.0% increase from a year earlier, with the FY2026 full-year figure at 9.9%, up 474.0% from the prior year.
• Return on Capital Employed improved to 10.67% in Q2 2026 per HQY's latest filing, from 9.98% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 10.67% in Q2 2026 and bottomed at 1.27% in Q3 2022.
• The 5-year median for Return on Capital Employed is 4.14% (2024), against an average of 3.81%.
• Across the five-year window, Return on Capital Employed slumped 219 bps in 2022 and surged 507 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 1.06% in 2022, then soared by 391 bps to 3.08% in 2023, then jumped by 54 bps to 4.75% in 2024, then jumped by 88 bps to 8.93% in 2025, then rose by 20 bps to 10.67% in 2026.
• Per Business Quant, the three latest HQY Return on Capital Employed figures stand at 10.67% (Q2 2026), 9.98% (Q1 2026), and 8.93% (Q4 2025).